Reported 0 shares, down 3,804 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 28000 |
| 2021-12-31 | 2377000 |
| 2022-03-31 | 636000 |
| 2022-06-30 | 436000 |
| 2022-09-30 | 0 |
| 2022-12-31 | 1419 |
| 2023-03-31 | 1117 |
| 2023-06-30 | 1034 |
| 2023-09-30 | 658 |
| 2023-12-31 | 817 |
| 2024-03-31 | 692 |
| 2024-06-30 | 2043 |
| 2024-09-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2024 | Reduced | 0 | -3,804 (-100.0%) | 0 | $0 | 2024-11-14 | |
| Q2 2024 | Added | 3,804 | +2,810 (282.7%) | < 0.01% | $2,043 | 2024-08-14 | |
| Q1 2024 | Unchanged | 994 | 0 (0.0%) | < 0.01% | $692 | 2024-05-15 | |
| Q4 2023 | Unchanged | 994 | 0 (0.0%) | < 0.01% | $817 | 2024-02-13 | |
| Q3 2023 | Unchanged | 994 | 0 (0.0%) | < 0.01% | $658 | 2023-11-15 | |
| Q2 2023 | Reduced | 994 | -112 (-10.1%) | < 0.01% | $1,034 | 2023-08-14 | |
| Q1 2023 | Reduced | 1,106 | -313 (-22.1%) | < 0.01% | $1,117 | 2023-05-15 | |
| Q4 2022 | Added | 1,419 | +1,020 (255.6%) | < 0.01% | $1,419 | 2023-02-14 | |
| Q3 2022 | Reduced | 399 | -334,984 (-99.9%) | 0 | $0 | 2022-11-14 | |
| Q2 2022 | Reduced | 335,383 | -100,844 (-23.1%) | < 0.01% | $436,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 436,227 | -675,126 (-60.7%) | < 0.01% | $636,000 | 2022-05-13 | |
| Q4 2021 | Added | 1,111,353 | +1,101,718 (11434.5%) | < 0.01% | $2,377,000 | 2022-02-14 | |
| Q3 2021 | Reduced | 9,635 | -25,383 (-72.5%) | < 0.01% | $28,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
33 managers reported FORTE BIOSCIENCES for Q3 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT LLC | Reduced | 0 | -346,292 | 0 | $0 | 18 qtrs |
| MORGAN STANLEY This report | Reduced | 0 | -3,804 | 0 | $0 | 18 qtrs |
| FARALLON CAPITAL MANAGEMENT LLC | Reduced | 0 | -1,810,455 | 0 | $0 | 5 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 0 | -26,817 | 0 | $0 | 18 qtrs |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP MA | Reduced | 0 | -193 | 0 | $0 | 18 qtrs |
| JPMorgan Chase & Co | Reduced | 0 | -17 | 0 | $0 | 14 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 0 | -133,400 | 0 | $0 | 11 qtrs |
| Tower Research Capital LLC TRC | Reduced | 0 | -15,798 | 0 | $0 | 5 qtrs |
| Aries Wealth Management | Reduced | 0 | -13,000 | 0 | $0 | 12 qtrs |
| UBS Group AG | Reduced | 0 | -24,310 | 0 | $0 | 17 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2024
- Filed
- November 14, 2024
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.